Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tosaki, A.
Right arrow Articles by Szekeres, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tosaki, A.
Right arrow Articles by Szekeres, L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DACTINOMYCIN
*DEXAMETHASONE

Stroke, Vol 16, 501-505, Copyright © 1985 by American Heart Association


ARTICLES

Actinomycin D suppresses the protective effect of dexamethasone in rats affected by global cerebral ischemia

A Tosaki, M Koltai, F Joo, G Adam, P Szerdahelyi, I Lepran, I Takats and L Szekeres

Simultaneous occlusion of both common carotid arteries in female Sprague-Dawley CFY rats produced characteristic symptoms of global cerebral ischemia, such as staggering, circling, convulsions, followed by coma and death. A close correlation existed among these symptoms and the elevation of water and Na+ content, appearing at the stage of staggering; Evans blue extravasation and diminution of K+ content, detected at circling; and the increase in Ca2+ content in the total brain tissue, manifesting itself at the phase of convulsions, indicating the development of cerebral edema due to ischemia. Dexamethasone given subcutaneously in a single 2.0 mg kg-1 dose 5 hours prior to the induction of global cerebral ischemia reduced considerably the morbidity and mortality, the alterations in water and electrolyte content, and albumin leakage in the brain tissue. Actinomycin D, in a dose of 0.5 mg kg-1 injected intravenously 1 hour before steroid treatment, abolished the beneficial effect. This finding suggests that de novo protein synthesis is involved in the cerebroprotective effect of dexamethasone.


This article has been cited by other articles:


Home page
StrokeHome page
J. W. Norris
Steroids May Have a Role in Stroke Therapy
Stroke, January 1, 2004; 35(1): 228 - 229.
[Full Text] [PDF]


Home page
StrokeHome page
J. Koistinaho, S. Koponen, P. H. Chan, and C. Y. Hsu
Expression of Cyclooxygenase-2 mRNA After Global Ischemia Is Regulated by AMPA Receptors and Glucocorticoids • Editorial Comment
Stroke, September 1, 1999; 30(9): 1900 - 1906.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Murakami, T. Kondo, C. J. Epstein, and P. H. Chan
Overexpression of CuZn-Superoxide Dismutase Reduces Hippocampal Injury After Global Ischemia in Transgenic Mice
Stroke, September 1, 1997; 28(9): 1797 - 1804.
[Abstract] [Full Text]